Header menu link for other important links
X
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
Published in
2009
PMID: 19459847
Volume: 100
   
Issue: 8
Pages: 1359 - 1365
Abstract
Chemotherapy, radiation, and surgery are the conventional treatment modalities for cancer. The success achieved with these approaches has been limited due to several factors like chemoresistance to drugs, non-specificity leading to peripheral toxicity, and non-resectable tumors. To combat these problems, the concept of targeted therapy using immunotoxins was developed. Immunotoxins are chimeric proteins with a cell-selective ligand chemically linked or genetically fused to a toxin moiety and can target cancer cells overexpressing tumor-associated antigens, membrane receptors, or carbohydrate antigens. Ligands for these receptors or monoclonal antibodies or single chain variable fragments directed against these antigens are fused with bacterial or plant toxins and are made use of as immunotoxins. Pseudomonas exotoxin, anthrax toxin, and diphtheria toxin are the commonly used bacterial toxins. Ricin, saporin, gelonin, and poke weed antiviral protein are the plant toxins utilized in immunotoxin constructs. Several such fusion proteins are in clinical trials, and denileukin difitox is a FDA-approved fusion protein. In spite of the promise shown by bacterial- and plant toxin-based chimeric proteins, their clinical application is hampered by several factors like immunogenicity of the toxin moiety and non-specific toxicity leading to vascular leak syndrome. In order to overcome these problems, a novel generation of immunotoxins in which the cytotoxic moiety is an endogenous protein of human origin like proapoptotic protein or RNase has been developed. This review summarizes the advances in this new class of fusion protein and the future directions to be explored. © 2009 Japanese Cancer Association.
About the journal
JournalCancer Science
ISSN13479032
Open AccessNo
Concepts (56)
  •  related image
    ANGIOGENIN CD30 ANTIGEN FUSION PROTEIN
  •  related image
    ANTHRAX TOXIN
  •  related image
    BACTERIAL TOXIN
  •  related image
    CASPASE ACTIVATED DEOXYRIBONUCLEASE
  •  related image
    CH2 CD30 ANTIGEN FUSION PROTEIN
  •  related image
    DENILEUKIN DIFTITOX
  •  related image
    Diphtheria toxin
  •  related image
    DNA
  •  related image
    EOSINOPHIL CATIONIC PROTEIN SINGLE CHAIN FRAGMENT VARIABLE FUSION PROTEIN
  •  related image
    EOSINOPHIL DERIVED NEUROTOXIN SINGLE CHAIN FRAGMENT VARIABLE FUSION PROTEIN
  •  related image
    GELONIN
  •  related image
    GONADORELIN CASPASE ACTIVATED DEOXYRIBONUCLEASE FUSION PROTEIN
  •  related image
    GONADOTROPIN BIK BAX BAK FUSION PROTEIN
  •  related image
    GRANZYME B SINGLE CHAIN FRAGMENT VARIABLE TARGETING THE MELANOMA GLYCOPROTEIN GP 240 FUSION PROTEIN
  •  related image
    GRANZYME B VASCULOTROPIN FUSION PROTEIN
  •  related image
    IMMUNOTOXIN
  •  related image
    INTERLEUKIN 2 BAX FUSION PROTEIN
  •  related image
    PANCREATIC RIBONUCLEASE
  •  related image
    POKEWEED MITOGEN
  •  related image
    PSEUDOMONAS EXOTOXIN
  •  related image
    RIBONUCLEASE
  •  related image
    RICIN
  •  related image
    SAPORIN
  •  related image
    SINGLE CHAIN FRAGMENT VARIABLE TARGETING THE CD7 ANTIGEN FAS LIGAND FUSION PROTEIN
  •  related image
    SINGLE CHAIN FRAGMENT VARIABLE TARGETING THE CD7 ANTIGEN TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND FUSION PROTEIN
  •  related image
    SINGLE CHAIN FRAGMENT VARIABLE TARGETING THE EPITHELIAL GLYCOPROTEIN 2 TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND FUSION PROTEIN
  •  related image
    Unclassified drug
  •  related image
    Apoptosis
  •  related image
    Cancer cell
  •  related image
    Cancer therapy
  •  related image
    Cytotoxicity
  •  related image
    Dna microarray
  •  related image
    DRUG APPROVAL
  •  related image
    Drug design
  •  related image
    Drug efficacy
  •  related image
    Drug receptor binding
  •  related image
    Drug targeting
  •  related image
    Gene expression
  •  related image
    Human
  •  related image
    Immunogenicity
  •  related image
    Nonhuman
  •  related image
    Priority journal
  •  related image
    Protein function
  •  related image
    Protein targeting
  •  related image
    Review
  •  related image
    TARGET CELL
  •  related image
    Upregulation
  •  related image
    Antibodies, monoclonal
  •  related image
    Bacterial toxins
  •  related image
    CLINICAL TRIALS AS TOPIC
  •  related image
    Forecasting
  •  related image
    Humans
  •  related image
    IMMUNOTOXINS
  •  related image
    Models, immunological
  •  related image
    Neoplasms
  •  related image
    Recombinant fusion proteins